CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infection

Carolyn Bolton Moore*, Edmund V. Capparelli, Pearl Samson, Mutsa Bwakura-Dangarembizi, Patrick Jean-Philippe, Carol Worrell, Barbara Heckman, Lynette Purdue, Stephen A. Spector, Alex Benns, William Borkowsky, Amy Loftis, Elizabeth Hawkins, Carole Wallis, Ellen G. Chadwick

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3-36 months with HIV infection'. Together they form a unique fingerprint.

Medicine & Life Sciences